Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5971-5983

  Mahjabeen, Ishrat ^a,b   Ali, Kashif ^a   Zhou, Xiaofeng ^b   Kayani, Mahmood Akhtar ^a  

^a COMSATS Institute of Information and Technology ^*  (Pakistan)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

BER pathway gene; HNSCC; Immunohistochemistry; Proliferation marker

Indexed keywords

APEX1 PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; OGG1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXCISION REPAIR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 84904752337     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1792-5     Document Type: Article

References (69)

1. Spitz M, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003;12:689-98. (Pubitemid 36993157)
2. Tudek B. Base excision repair modulation as a risk factor for human cancers. Mol Asp Med. 2007;28:258-75. (Pubitemid 47331613)
3. Mitra S, Izumi T, Boldogh I, Bhakat KK, Hill JW, Hazra TK. Choreography of oxidative damage repair in mammalian genomes. Free Radic Biol Med. 2002;33:15-28. (Pubitemid 34681002)
4. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, et al. Genetic polymorphisms and altered splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219-25. (Pubitemid 28330419)
5. Campalans A, Marsin S, Nakabeppu Y, O'connor TR, Boiteux S, Radicella JP. XRCC1 interactions withmultipleDNA glycosylases: a model for its recruitment to base excision repair. DNA Repair. 2005;4:826-35. (Pubitemid 40835854)
6. Fan CY, Liu KL, Huang HY, Barnes EL, Swalsky PA, Bakker A, et al. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res. 2004;32:2193-201.
7. Kumar A, Pant MC, Singh SH, Khandelwal S. Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India. Tumor Biol. 2012;33(1):111-9.
8. Fortini P, Pascucci B, Parlanti E, D'Errico M, Simonelli V, Dogliotti E. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie. 2003;85:1053-71. (Pubitemid 38142361)
9. Parsons JL, Dianova I, Dianov GL. APE1 is the major 3′- phosphoglycolate activity in human cell extracts. Nucleic Acids Res. 2004;32:3531-6. (Pubitemid 39157703)
10. Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001;20:6530-9. (Pubitemid 33078725)
11. Sossou M, Flohr-Beckhaus C, Schulz I, Daboussi F, Epe B, Radicella JP. APE1 overexpression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability. Nucleic Acids Res. 2005;33(1):298-306. (Pubitemid 40276951)
12. Ashraf MJ, Maghbul M, Azarpira N, Khademi B. Expression of Ki67 and P53 in primary squamous cell carcinoma of the larynx. Indian J Pathol Microbiol. 2010;53:661-5.
13. Tang QL, Fan S, Li HG, Chen WL, Shen XM, Yuan XP, et al. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis. Oral Oncol. 2011;47:365-70.
14. Okabe M, Inagaki H, Murase T, Inoue M, Nagai N, Eimoto T. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Mod Pathol. 2001;14:1008-14. (Pubitemid 32976789)
15. Schmilovitz-Weiss H, Tobar A, Halpern M, Levy I, Shabtai E, Ben-Ari Z. Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study. Diagn Pathol. 2011;6:121.
16. Faratian D, Munro A, Twelves C, Bartlett JM. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology. 2009;54:254-7.
17. 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Nucl Med Commun. 2009;30:831-7.
18. Fischer CA, Jung M, Zlobec I, Green E, Storck C, Tornillo L, et al. Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis. Head Neck. 2011;33:267-73.
19. Mahjabeen I, Baig RM, Masood N, Sabir M, Malik FA, Kayani MA. OGG1 Gene sequence variation in head and neck cancer patients in Pakistan. Asian Pac J Cancer Prev. 2011;12:2779-83.
20. Mahjabeen I, Baig RM, Masood N, Sabir M, Inayat U, Malik FA, et al. Novel mutations of OGG1 base excision repair pathway gene in laryngeal cancer patients. Fam Cancer. 2012;11(4):587-93.
21. Mahjabeen I, Baig RM, Sabir M, Kayani MA. Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer. Mutagenesis. 2013;28(2):213-8.
22. Mahjabeen I, Baig RM, Masood N, Sabir M, Inayat U, Malik FA, et al. Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res. 2012;19(20):183-8.
23. Mahjabeen I, Chen Z, Zhou X, Kayani MA. Decreased mRNA expression levels of base excision repair (BER) pathway genes is associated with enhanced Ki-67 expression in HNSCC. Med Oncol. 2012;29(5):3620-5.
24. Wang YX, Sun YE, Li XH, Wang ZB, Tong XY, Liu YL. Comparative study on molecular staging of lymph nodes in nonsmall cell lung cancer patients. Ai Zheng. 2009;28(3):318-22.
25. Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, Al-Nabhani M, et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol. 2005;91(4):243-52. (Pubitemid 41266821)
26. Mambo E, Chatterjee A, Souza-Pinto NC, Mayard S, Hogue BA, Hoque M, et al. Oxidized guanine lesions and hOgg1 activity in lung cancer. Oncogene. 2005;24:4496-508. (Pubitemid 41032613)
27. Kunisada M, Sakumi K, Tominaga Y, Budiyanto A, Ueda M, Ichihashi M, et al. 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis. Cancer Res. 2005;65:6006-10. (Pubitemid 40994382)
28. Huang XX, Scolyer RA, Abubakar A, Halliday GM. Human 8-oxoguanine-DNA glycosylase-1 is downregulated in human basal cell carcinoma. Mol Genet Metab. 2012;106:127-30.
29. Karihtala P, Kauppila S, Puistola U, Jukkola-Vuorinen A. Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype. Br J Cancer. 2012;106:344-7.
30. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer. 2008;123:601-8. (Pubitemid 351898418)
31. Ku YP, Jin M, Kim KH, Ahn YJ, Yoon SP, You HJ, et al. Immunolocalization of 8-OHdG and OGG1 in pancreatic islets of streptozotocin-induced diabetic rats. Acta Histochem. 2009;111:138-44.
32. Preston TJ, Henderson JT, McCallum GP, Wells PG. Base excision repair of reactive oxygen species-initiated 7, 8-dihydro-8-oxo-2′-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs. Mol Cancer Ther. 2009;8(7):2015-26.
33. Moore DH, Michael H, Tritt R, Parsons SH, Kelley MR. Alternations in the expression of the DNA repair/ redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res. 2000;6:602-9. (Pubitemid 30111485)
34. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, et al. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res. 2001;7:824-30. (Pubitemid 32708717)
35. Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, et al. Apurinic/apyrimidinic endonuclease activity is associatedwith response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors. Clin Cancer Res. 2005;11(20):7405-14. (Pubitemid 41507701)
36. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens FLJ. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/ref-1 inhibitor. Mol Cancer Ther. 2005;4(12):1923-35. (Pubitemid 43056975)
37. Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZV, Fite A, Zhang H, et al. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res. 2007;67(5):2141-9. (Pubitemid 46424233)
38. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, et al. MicroRNA-7 targets insulin-like growth factor 1 receptor (IGF1R) in tongue squamous cell carcinoma cells. Biochem J. 2010;432:199-205.
39. Fishel ML, Jiang Y, Rajeshkumar NV, Scandura G, Sinn AL, He Y, et al. Impact of APE1/ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther. 2011;10(9):1698-708.
40. Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, Kelley MR. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1α and prognostic significance. Int J Oncol. 2001;19:799-802.
41. Freitas S, Moore DH, Michael H, Kelley MR. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinumresistance. Clin Cancer Res. 2003;9:4689-94. (Pubitemid 37323270)
42. Lee JW, Jin J, Rha KS, Kim YM. Expression pattern of apurinic/ apyrimidinic endonuclease in sinonasal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2012;147(4):788-95.
43. Ford BN, Ruttan CC, Kyle VL, Brackley ME, Glickman BW. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis. 2000;21:1977-81.
44. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001;22:917-22. (Pubitemid 32514958)
45. Liu W, AO L, Cui Z, Zhou Z, Zhou Y, Yuan X, et al. Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis. Biochem Biophys Res Commun. 2011;408:595-601.
46. Wang P, Tang JT, Peng YS, Chen XY, Zhang YJ, Fang JY. XRCC1 downregulated through promoter hypermethylation is involved in human gastric carcinogenesis. J Dig Dis. 2010;11:343-51.
47. Wang S, Wu X, Chen Y, Zhang J, Ding J, Zhou Y, et al. Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. Clin Cancer Res. 2012;18(10):2987-96.
48. Chetty C, Dontula R, Gujrati M, Dinh DH, Lakka SS. Blockade of SOX4 mediated DNA repair by SPARC enhances radioresponse in medulloblastoma. Cancer Lett. 2012;323:188-98.
49. Sak SC, Harnden P, Johnston CF, Paul AB, Kiltie AE. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res. 2005;11:6205.
50. Cheng X, Lu W, Ye F, Wan X, Xie X. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. J Exp Clin Cancer Res. 2009;28:91.
51. Kang CH, Jang BG, Kim DW, Chung DH, Kim YT, Jheon S, et al. The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection. Lung Cancer. 2010;68:478-83.
52. Ang MK, Patel MR, Yin XY, Sundaram S, Fritchie K, Zhao N, et al. High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2011;17(20):6542-52.
53. Rybarova S, Vecanova J, Hodorova I, Mihalik J, Cizmarikova M, Mojzis J, et al. Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. Med Sci Monit. 2011;17:BR354-63.
54. Fujimura M, Morita-Fujimura Y, Noshita N, Yoshimoto T, Chan PH. Reduction of the DNA base excision repair protein, XRCC1, may contribute to DNA fragmentation after cold injury-induced brain trauma in mice. Brain Res. 2000;869:105-11.
55. Rodrigues RB, Motta Rda R, Machado SM, Cambruzzi E, Zettler EW, Zettler CG, et al. Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx. Braz J Otorhinolaryngol. 2008;74:855-9.
56. Kim SJ, Shin HJ, Jung K, Baek S, Shin BK, Choi J, et al. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J Clin Oncol. 2007;37:812-9. (Pubitemid 350258999)
57. Szczuraszek K, Mazur G, Jelen M, Dziegiel P, Surowiak P, Zabel M. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas. Anticancer Res. 2008;28:1113-8. (Pubitemid 351578962)
58. Cheang MCU, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. JNCI. 2009;101(10):736-50.
59. Sym S, Hong J, Cho E, Lee W, Chung M, Ha S, Park Y, Park J, Lee J, Shin D (2011) Prognostic impact of immunohistochemical expression of Ki-67 in patients with advanced gastric cancer who underwent curative Resection. J Clin Oncol 29
60. Jiang Y, Cheng B, Ge M, Zhang G. The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma. Head Neck Oncol. 2012;4:9.
61. Habib SL. Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients. Mol Cancer. 2009;8:13.
62. Jiang Y, Zhou S, Sandusky GE, Kelley MR, Fishel ML. Reduced expression of DNA repair and redox signaling protein APE1/ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer Investig. 2010;228:885-95.
63. Al-Attar A, Gossage L, Fareed KR, Shehata M, Mohammed M, Zaitoun AM, et al. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastrooesophageal and pancreatico-biliary cancers. Br J Cancer. 2010;102:704-9.
64. Grosch S, Kaina B. Transcriptional activation of apurinic/apyrimidinic endonuclease (Ape, ref-1) by oxidative stress requires CREB. Biochem Biophys Res Commun. 1999;261:859-63. (Pubitemid 29408148)
65. Vaezi A, Feldman CH, Niedernhofer LJ. ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer. Pharmgenomics Pers Med. 2011;4:47-63.
66. Krskova L, Kalinova M, Brizova H, Mrhalova M, Sumerauer D, Kodet R. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma. Cancer Genet Cytogenet. 2009;193:1-8.
67. Brouwer-Visser J, Cossio MJ, Chao SK, Huang GS. Effect of IGF2 overexpression on the tumorigenicity of human ovarian carcinoma cells. Cancer Res. 2012;72:1.
68. Ma J, Li J, Li H, Xiao X, Shen L, Fang L. Downregulation of pancreatic-duodenal homeobox 1 expression in breast cancer patients: a mechanism of proliferation and apoptosis in cancer. Mol Med Rep. 2012;6:983-8.
69. Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23:7212-20.